{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_51460"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_51460","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"NEAR-INFRARED PHOTOIMMUNOTHERAPY TARGETING OF CANCER-ASSOCIATED FIBROBLASTS","abstract":"Cancer-associated fibroblasts (CAFs) constitute a prominent cellular component of the tumor stroma, representing a heterogeneous group of activated fibroblasts. Within the tumor microenvironment (TME), CAFs play various pro-tumorigenic roles, including extracellular matrix remodeling, suppression of anti-tumor immunity, and modulation of tumor cell resistance to therapy. Fibroblast activation protein (FAP), a highly expressed marker on immunosuppressive CAFs, has been identified in several epithelial human cancers such as lung, colon, breast, and prostate cancer. Numerous attempts to target FAP+CAFs for inhibiting tumor progression and enhancing anti-tumor immunity have been reported, however, the translation of FAP-directed therapies into human clinical trials has been unsuccessful. Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective tumor therapy that utilizes an antibody-photo-absorbing conjugate activated by near-infrared (NIR) light. In this study, we describe the therapeutic efficacy of anti-FAP near-infrared photoimmunotherapy (NIR-PIT) and subsequent immune activation in two immune-competent murine cancer models. Targeting FAP+ cells effectively suppressed tumor growth and reduced lung metastasis in a spontaneous mouse model of mammary cancer. These findings highlight a promising therapeutic approach for selectively and safely eliminating immunosuppressive FAP+ cells within the tumor microenvironment.","abstract_html":"Cancer-associated fibroblasts (CAFs) constitute a prominent cellular component of the tumor stroma, representing a heterogeneous group of activated fibroblasts. Within the tumor microenvironment (TME), CAFs play various pro-tumorigenic roles, including extracellular matrix remodeling, suppression of anti-tumor immunity, and modulation of tumor cell resistance to therapy. Fibroblast activation protein (FAP), a highly expressed marker on immunosuppressive CAFs, has been identified in several epithelial human cancers such as lung, colon, breast, and prostate cancer. Numerous attempts to target FAP+CAFs for inhibiting tumor progression and enhancing anti-tumor immunity have been reported, however, the translation of FAP-directed therapies into human clinical trials has been unsuccessful. Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective tumor therapy that utilizes an antibody-photo-absorbing conjugate activated by near-infrared (NIR) light. In this study, we describe the therapeutic efficacy of anti-FAP near-infrared photoimmunotherapy (NIR-PIT) and subsequent immune activation in two immune-competent murine cancer models. Targeting FAP+ cells effectively suppressed tumor growth and reduced lung metastasis in a spontaneous mouse model of mammary cancer. These findings highlight a promising therapeutic approach for selectively and safely eliminating immunosuppressive FAP+ cells within the tumor microenvironment.","abstract_has_math":false,"creators":["Glabman, Raisa A"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Hussey, Gisela","Simpson, R. Mark","Agnew, Dalen","Petroff, Margaret","Choyke, Peter"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-18T18:58:05Z","subjects":["Cytology","Veterinary medicine","Immunology"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:51460","local:Glabman_grad.msu_0128D_20264"],"render_values":[{"text":"etd:51460","href":null,"code":true},{"text":"local:Glabman_grad.msu_0128D_20264","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/f5f4-9463","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/f5f4-9463","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_51460","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Hussey, Gisela","Simpson, R. Mark","Agnew, Dalen","Petroff, Margaret","Choyke, Peter"]},{"key":"dc:creator","label":"Author","values":["Glabman, Raisa A"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cytology","Veterinary medicine","Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:51460","local:Glabman_grad.msu_0128D_20264","https://doi.org/doi:10.25335/f5f4-9463"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Cancer-associated fibroblasts (CAFs) constitute a prominent cellular component of the tumor stroma, representing a heterogeneous group of activated fibroblasts. Within the tumor microenvironment (TME), CAFs play various pro-tumorigenic roles, including extracellular matrix remodeling, suppression of anti-tumor immunity, and modulation of tumor cell resistance to therapy. Fibroblast activation protein (FAP), a highly expressed marker on immunosuppressive CAFs, has been identified in several epithelial human cancers such as lung, colon, breast, and prostate cancer. Numerous attempts to target FAP+CAFs for inhibiting tumor progression and enhancing anti-tumor immunity have been reported, however, the translation of FAP-directed therapies into human clinical trials has been unsuccessful. Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective tumor therapy that utilizes an antibody-photo-absorbing conjugate activated by near-infrared (NIR) light. In this study, we describe the therapeutic efficacy of anti-FAP near-infrared photoimmunotherapy (NIR-PIT) and subsequent immune activation in two immune-competent murine cancer models. Targeting FAP+ cells effectively suppressed tumor growth and reduced lung metastasis in a spontaneous mouse model of mammary cancer. These findings highlight a promising therapeutic approach for selectively and safely eliminating immunosuppressive FAP+ cells within the tumor microenvironment.","Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2023","Includes bibliographical references"]},{"key":"dc:format","label":"Dc Format","values":["105 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["NEAR-INFRARED PHOTOIMMUNOTHERAPY TARGETING OF CANCER-ASSOCIATED FIBROBLASTS"]}]}],"canonical_facts":{"dc:contributor":["Hussey, Gisela","Simpson, R. Mark","Agnew, Dalen","Petroff, Margaret","Choyke, Peter"],"dc:creator":["Glabman, Raisa A"],"dc:date":["2023"],"dc:description":["Cancer-associated fibroblasts (CAFs) constitute a prominent cellular component of the tumor stroma, representing a heterogeneous group of activated fibroblasts. Within the tumor microenvironment (TME), CAFs play various pro-tumorigenic roles, including extracellular matrix remodeling, suppression of anti-tumor immunity, and modulation of tumor cell resistance to therapy. Fibroblast activation protein (FAP), a highly expressed marker on immunosuppressive CAFs, has been identified in several epithelial human cancers such as lung, colon, breast, and prostate cancer. Numerous attempts to target FAP+CAFs for inhibiting tumor progression and enhancing anti-tumor immunity have been reported, however, the translation of FAP-directed therapies into human clinical trials has been unsuccessful. Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective tumor therapy that utilizes an antibody-photo-absorbing conjugate activated by near-infrared (NIR) light. In this study, we describe the therapeutic efficacy of anti-FAP near-infrared photoimmunotherapy (NIR-PIT) and subsequent immune activation in two immune-competent murine cancer models. Targeting FAP+ cells effectively suppressed tumor growth and reduced lung metastasis in a spontaneous mouse model of mammary cancer. These findings highlight a promising therapeutic approach for selectively and safely eliminating immunosuppressive FAP+ cells within the tumor microenvironment.","Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2023","Includes bibliographical references"],"dc:format":["105 pages","application/pdf"],"dc:identifier":["etd:51460","local:Glabman_grad.msu_0128D_20264","https://doi.org/doi:10.25335/f5f4-9463"],"dc:language":["English"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Cytology","Veterinary medicine","Immunology"],"dc:title":["NEAR-INFRARED PHOTOIMMUNOTHERAPY TARGETING OF CANCER-ASSOCIATED FIBROBLASTS"],"dc:type":["Text","Theses"]},"updated_at":"2026-11-18T18:58:05Z"}